DoD awards $10.7 million Center of Excellence Grant to Fox Chase's V. Craig Jordan

V. Craig Jordan, OBE, Ph.D., D.Sc., of Fox Chase Cancer Center has received a $10.7 million grant from the Department of Defense Breast Cancer Research Program for a Breast Cancer Center of Excellence focused on developing a new treatment model for breast cancer to reverse the eventual development of resistance to anti-estrogen therapy. The five-year multidisciplinary project, intended to encompass both laboratory research and clinical trials, involves scientists and physicians at Fox Chase and three other institutions, representing four task teams.

"The DoD Breast Cancer Research Program is pleased to support this innovative project by Dr. Jordan, his collaborators and Fox Chase Cancer Center to address a critical issue in breast cancer--the identification of new therapeutic drugs to treat women with breast cancer," said Col. Janet R. Harris, M.S.N., Ph.D., director of the Congressionally Directed Medical Research Programs administering the DoD Breast Cancer Research Program. "Through this project, new treatments will be brought from the laboratory to stage I and II clinical trials, facilitating the process for making new breast cancer therapeutic drugs available sooner."

This is Fox Chase's second Center of Excellence grant received in five years. In 2001, the Department of Defense awarded a $6 million dollar grant for the development of the nation's first Behavioral Center of Excellence for Breast Cancer Research.

Medical oncologist Lori J. Goldstein, M.D., director of Fox Chase's multidisciplinary Breast Evaluation Center, is Jordan's co-principal investigator for the new Center of Excellence grant. Jordan is vice president and scientific director of medical science at Fox Chase and holds its Alfred G. Knudson Jr., M.D., Ph.D., Chair in Cancer Research.

Jordan is known as the "father of tamoxifen" for his seminal work that led to the validation of tamoxifen as a therapy targeted to treat breast cancer and the first-ever

Contact: Diana Quattrone
Fox Chase Cancer Center

Page: 1 2 3 4

Related biology news :

1. Argonne wins three R&D 100 awards for innovative technologies
2. ASBMB taps 8 scientists and 1 politician for top awards
3. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
4. US Department of Defense awards $1.6 million for implantable biochip research
5. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
6. The Cancer Genome Atlas awards funds for technology development
7. NIH awards nearly $21 million to fund cutting-edge research equipment
8. SNM presents awards on Capitol Hill
9. National awards for 2 University of York scientists
10. Burroughs Wellcome Fund awards $14M to support physician-scientists
11. NIH awards VBI, Mayo Clinic $2.4M to study chronic rhinosinusitis

Post Your Comments:

(Date:3/18/2019)... ... 2019 , ... Periodontal disease, where bacterial infection of the gums causes chronic ... population. Making this disease particularly challenging to treat is the fact that the ... in a sticky extracellular material that makes them more resistant to antibiotic treatment. ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... on Mac, Windows and mobile, today announces the launch of its North American ... volume, geographies and vertical markets, enabling them to add FileWave’s industry-leading solutions to ...
(Date:3/13/2019)... EGG HARBOR, N.J. (PRWEB) , ... March 13, 2019 , ... ... detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce ... changed ownership in early February 2019 and the newly installed and highly experienced ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... ... March 11, 2019 , ... Centura Health, the region’s ... the first in the nation, to offer needle-free blood draws for inpatients. , ... degree to which staff showed compassion jumped up by an average of 15.4% ...
(Date:3/9/2019)... (PRWEB) , ... March 07, 2019 , ... ... is a pioneer in the development and commercialization of high performance, cutting-edge cell ... a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are ...
(Date:3/4/2019)... ... ... hot topics through free webinars presented by leading experts in pharma, biotech, medical device and ... save your place! Participate in the discussion and stay relevant in your field! , Visit ... March 20 – Implementing BYOD Across Phase II and III Clinical Trials , ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... emerging leader in the rapidly growing NGS (Next Generation Sequencing) field, have announced ... laboratory and incubator. , "As an innovation center and idea incubator, we are ...
Breaking Biology Technology:
Cached News: